Increased growth of vascular smooth muscle cells in hypertension may be a primary event driven by endogenous Ang II-related growth factors rather than just a consequence of high blood pressure.
Answers are grounded in this paper and cite their sources.
May support local Ang II as a driver of VSMC growth in hypertensive models; hypothesis-generating and does not yet inform clinical practice.
The molecular mechanisms of the exaggerated growth of vascular smooth muscle cells (VSMC) in hypertension are reviewed based on our previous experimental data. Spontaneously hypertensive rats (SHR)-derived VSMC increasingly express angiotensinogen, cathepsin D and angiotensin-converting enzyme (ACE) mRNAs, compared to cells from normotensive Wistar-Kyoto (WKY) rats, indicating the presence of an Ang II generating system in a homogeneous culture of VSMC from SHR. The produced Ang II then induces TGF-beta. SHR-derived VSMC show the distinct expression and abnormal regulation by Ang II of TGF-beta receptors when compared with cells from WKY rats, which express TGF-beta type II receptor predominantly to induce PDGF A-chain stimulation of VSMC growth. These findings imply that the increased growth of VSMC in hypertension is a primary event independent of high blood pressure, and is associated with endogenous Ang II-related growth factors.
No takes yet. Share an insight, caveat, or question.
Noboru Fukuda (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: